Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
QJM : Monthly Journal of the Association of Physicians
|
June 8, 2001
MHC and the viral hepatitides
M Thursz
Biotechnology & Genetic Engineering Reviews
|
March 21, 2001
Genetic susceptibility in infectious diseases
M Thursz
Antiviral Research
|
October 24, 2001
Genetic susceptibility in chronic viral hepatitis
M Thursz
Journal of Viral Hepatitis
|
May 16, 2014
Prevention of materno-foetal transmission of hepatitis B in sub-Saharan Africa: the evidence, current practice and future challenges
J Howell, M Lemoine, M Thursz
Journal of Viral Hepatitis
|
April 10, 2014
Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward)
G J Dore, J Ward, M Thursz
Journal of Viral Hepatitis
|
December 24, 2014
Welcome to the new, all electronic Journal of Viral Hepatitis
G Foster, N H Afdhal, P Karayiannis, et al.
Alimentary Pharmacology & Therapeutics
|
February 6, 2014
Commentary: how long does one need to fast before a Fibroscan examination? Authors' reply
M Lemoine, Y Shimakawa, S Nayagam, et al.
European Journal of Immunology
|
July 24, 2001
Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients
A Godkin, N Jeanguet, M Thursz, et al.
Lancet (London, England)
|
December 28, 1999
Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research
M Thursz, R Yallop, R Goldin, et al.
British Journal of Cancer
|
April 1, 2015
Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review
T Kimhofer, H Fye, S Taylor-Robinson, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
QJM : Monthly Journal of the Association of Physicians
|
June 8, 2001
MHC and the viral hepatitides
M Thursz
Biotechnology & Genetic Engineering Reviews
|
March 21, 2001
Genetic susceptibility in infectious diseases
M Thursz
Antiviral Research
|
October 24, 2001
Genetic susceptibility in chronic viral hepatitis
M Thursz
Journal of Viral Hepatitis
|
May 16, 2014
Prevention of materno-foetal transmission of hepatitis B in sub-Saharan Africa: the evidence, current practice and future challenges
J Howell, M Lemoine, M Thursz
Journal of Viral Hepatitis
|
April 10, 2014
Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward)
G J Dore, J Ward, M Thursz
Journal of Viral Hepatitis
|
December 24, 2014
Welcome to the new, all electronic Journal of Viral Hepatitis
G Foster, N H Afdhal, P Karayiannis, et al.
Alimentary Pharmacology & Therapeutics
|
February 6, 2014
Commentary: how long does one need to fast before a Fibroscan examination? Authors' reply
M Lemoine, Y Shimakawa, S Nayagam, et al.
European Journal of Immunology
|
July 24, 2001
Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients
A Godkin, N Jeanguet, M Thursz, et al.
Lancet (London, England)
|
December 28, 1999
Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research
M Thursz, R Yallop, R Goldin, et al.
British Journal of Cancer
|
April 1, 2015
Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review
T Kimhofer, H Fye, S Taylor-Robinson, et al.
Page
of 5